Articles: Genitourinary Cancers

Paradigm towards Tailored Therapies and Complete Responses in the Treatment of Metastatic Renal Cell Carcinoma
Mayer Fishman, Thomas E Hutson, Neeraj Agarwal, Eric Jonasch
Oncology & Hematology Review (US)
Cabazitaxel in the Management of Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel-based Chemotherapy
Axel Heidenreich, David Pfister
Oncology & Hematology Review (US)
Surgery of the Primary Tumour in Stage IV Colorectal Cancer with Unresectable Metastases
Ninos Ayez, Wijnand J Alberda, Henk M Verheul, Jacobus W Burger, Johannes H de Wilt, Cornelis Verhoef
European Oncology & Haematology
VAL 201 – An Inhibitor of Androgen Receptor-associated Src and a Potential Treatment of Castration-resistant Prostate Cancer
Ferdinando Auricchio, Antimo Migliaccio
European Oncology & Haematology
Docetaxel Rechallenge in Patients with Castration-resistant Prostate Cancer – A Review
Orazio Caffo, Giovanni Pappagallo, Lucianna Maria Russo, Antonello Veccia, Enzo Galligioni
European Oncology & Haematology
Cabazitaxel in the Management of Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel-based Chemotherapy
Axel Heidenreich, David Pfister
European Oncology & Haematology
Obesity in the Elderly – On the Role of Adipokines in Prostate Cancer Progression
Adriano Angelucci, Mauro Bologna
European Oncology & Haematology
Localized Prostate Cancer—What the Medical Oncologist Needs to Know
Aditya Bardia, Michael A Carducci
Oncology & Hematology Review (US)
Treatment Strategies in Metastatic Renal Cell Carcinoma
Alain Ravaud, Jean Christophe Bernhard, Marine Gross-Goupil
European Oncology & Haematology
Immune Self-tuning in Renal Cell Carcinoma
Antonia Busse, Ulrich Keilholz
European Oncology & Haematology
Improving the Outcome of Patients with Castration-resistant Prostate Cancer Through Rational Targeting of the Androgen Receptor
Chris Parker, Johann S De Bono, Gerhardt Attard
European Oncology & Haematology
Therapeutic Approach to Castration-resistant Prostate Cancer
Fred Saad
Oncology & Hematology Review (US)
Advances in the Treatment Options for Kidney Cancer— Is There an Optimal Regimen?
Gihan Ratnayake, James Larkin, Lisa Pickering
Oncology & Hematology Review (US)
Therapeutic Approach to Castration-resistant Prostate Cancer
Fred Saad
European Oncology & Haematology
The Future of Therapy for Advanced Renal Cell Cancer
Thomas E Hutson, Guru Sonpavde, Cora N Sternberg
European Oncology & Haematology
Advances in the Treatment of Castration-resistant Prostate Cancer
Ian D Davis
Therapeutic Approach to Castration-resistant Prostate Cancer
Fred Saad
Androgen-deprivation Therapy— A Help or a Hindrance for Survival in High-risk Prostate Cancer?
L Christine Fang, Gregory S Merrick, Kent Wallner
Oncology & Hematology Review (US)
Maintaining Bone Health and Integrity During Androgen-deprivation Therapy for Prostate Cancer
Thomas J Polascik
Oncology & Hematology Review (US)
Developing Treatments for Hormone-refractory Prostate Cancer
Alan J Koletsky
Oncology & Hematology Review (US)
Salvage Cryosurgery in Prostate Cancer
Aaron E Katz
Oncology & Hematology Review (US)
High-dose-rate Brachytherapy of Prostate Cancer
D Jeffrey Demanes, Dennis R Hill
European Oncology & Haematology
Current Treatment Standards in Metastatic Colorectal Cancer— The Role of Anti-epidermal Growth Factor Antibodies
Eric Van Cutsem
Oncology & Hematology Review (US)
Diagnostic Imaging Approaches to Prostate Cancer
Edouard J Trabulsi, Leonard G Gomella
Oncology & Hematology Review (US)
High-dose-rate Brachytherapy of Prostate Cancer
D Jeffrey Demanes, Dennis R Hill
Oncology & Hematology Review (US)
Therapeutic Treatment of Hepatic Colorectal Metastases
Jason K Sicklick, Timothy M Pawlik
Oncology & Hematology Review (US)
Recurrent Prostate Cancer After Radiotherapy – Salvage Treatment by High-intensity Focused Ultrasound
A Gelet, François-Joseph Murat, L Poissonier
European Oncology & Haematology
Therapeutic Approach to Hormone-refractory Prostate Cancer
Fred Saad
Oncology & Hematology Review (US)
The Use of Doxil® (Caelyx®) for the Treatment of Prostate Cancer—Past, Present, and Future
Christina Voelkel-Johnson
Oncology & Hematology Review (US)
Current Management of Bladder Cancer
Guru Sonpavde, Matthew D Galsky, Thomas E Hutson
Oncology & Hematology Review (US)